デフォルト表紙
市場調査レポート
商品コード
1434447

医療における人工知能市場:タイプ、用途、エンドユーザー別-2024-2030年の世界予測

Artificial Intelligence in Medicine Market by Type (Hardware, Services, Software), Application (Disease Diagnosis & Identification, Patient Care, Research & Drug Invention), End User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
医療における人工知能市場:タイプ、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療における人工知能市場規模は2023年に44億4,000万米ドルと推計され、2024年には58億5,000万米ドルに達すると予測され、CAGR 31.97%で2030年には309億7,000万米ドルに達する見込みです。

医療における人工知能の世界市場

主な市場の統計
基準年[2023] 44億4,000万米ドル
予測年[2024] 58億5,000万米ドル
予測年 [2030] 309億7,000万米ドル
CAGR(%) 31.97%
医療における人工知能 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは医療における人工知能市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、医療における人工知能市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-医療における人工知能市場の市場規模および予測は?

2-医療における人工知能市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-医療における人工知能市場における技術動向と規制の枠組みは?

4-医療における人工知能市場における主要ベンダーの市場シェアは?

5-医療における人工知能市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 創薬効率向上への需要の高まり
      • ヘルスケア費削減のニーズの増加
      • コスト削減を実現するためにデジタルトランスフォーメーション実践の導入がますます重視される
    • 抑制要因
      • 熟練した専門家の不足
    • 機会
      • 人間を意識した人工知能システムの開発への注目の高まり
      • 精密医療の重要性が高まる
    • 課題
      • データプライバシーに関する懸念の高まり
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 医療における人工知能市場:タイプ別

  • ハードウェア
  • サービス
  • ソフトウェア

第7章 医療における人工知能市場:用途別

  • 病気の診断と特定
  • 患者ケア
  • 調査と創薬

第8章 医療における人工知能市場:エンドユーザー別

  • アカウンタブル・ケア組織とマネージド・ケア組織
  • 患者
  • 支払者
  • 製薬およびバイオテクノロジー企業
  • プロバイダー

第9章 南北アメリカの医療における人工知能市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の医療における人工知能市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの医療における人工知能市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Atomwise, Inc.
    • BenevolentAI
    • Berg LLC
    • Bioxcel Therapeutics, Inc.
    • Enlitic Inc.
    • Google LLC by Alphabet Inc.
    • InSilico Medicine
    • Intel Corporation
    • International Business Machines Corporation
    • Microsoft Corporation
    • NVIDIA Corporation
    • PathAI, Inc.
    • Recursion Pharmaceuticals, Inc.
    • Tempus Labs, Inc.
    • Verge Analytics, Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET DYNAMICS
  • FIGURE 7. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS & IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY RESEARCH & DRUG INVENTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ACCOUNTABLE CARE ORGANIZATIONS & MANAGED CARE ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PAYERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 147. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET LICENSE & PRICING
目次
Product Code: MRR-4330CC794AAE

[193 Pages Report] The Artificial Intelligence in Medicine Market size was estimated at USD 4.44 billion in 2023 and expected to reach USD 5.85 billion in 2024, at a CAGR 31.97% to reach USD 30.97 billion by 2030.

Global Artificial Intelligence in Medicine Market

KEY MARKET STATISTICS
Base Year [2023] USD 4.44 billion
Estimated Year [2024] USD 5.85 billion
Forecast Year [2030] USD 30.97 billion
CAGR (%) 31.97%
Artificial Intelligence in Medicine Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Intelligence in Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Intelligence in Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Medicine Market, highlighting leading vendors and their innovative profiles. These include Atomwise, Inc., BenevolentAI, Berg LLC, Bioxcel Therapeutics, Inc., Enlitic Inc., Google LLC by Alphabet Inc., InSilico Medicine, Intel Corporation, International Business Machines Corporation, Microsoft Corporation, NVIDIA Corporation, PathAI, Inc., Recursion Pharmaceuticals, Inc., Tempus Labs, Inc., and Verge Analytics, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Hardware
    • Services
    • Software
  • Application
    • Disease Diagnosis & Identification
    • Patient Care
    • Research & Drug Invention
  • End User
    • Accountable Care Organizations & Managed Care Organizations
    • Patients
    • Payers
    • Pharmaceutical & Biotechnology Companies
    • Providers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Artificial Intelligence in Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Intelligence in Medicine Market?

3. What are the technology trends and regulatory frameworks in the Artificial Intelligence in Medicine Market?

4. What is the market share of the leading vendors in the Artificial Intelligence in Medicine Market?

5. Which modes and strategic moves are suitable for entering the Artificial Intelligence in Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Artificial Intelligence in Medicine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand to improve the efficiency of drug discovery
      • 5.1.1.2. Increase in need to reduce healthcare costs
      • 5.1.1.3. Increased emphasis on adoption of digital transformation practices to realize cost savings
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising focus on developing human-aware artificial intelligence systems
      • 5.1.3.2. Growing importance of precision medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Growing concerns regarding data privacy
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Artificial Intelligence in Medicine Market, by Type

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
  • 6.4. Software

7. Artificial Intelligence in Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Disease Diagnosis & Identification
  • 7.3. Patient Care
  • 7.4. Research & Drug Invention

8. Artificial Intelligence in Medicine Market, by End User

  • 8.1. Introduction
  • 8.2. Accountable Care Organizations & Managed Care Organizations
  • 8.3. Patients
  • 8.4. Payers
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Providers

9. Americas Artificial Intelligence in Medicine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Intelligence in Medicine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Intelligence in Medicine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Atomwise, Inc.
    • 13.1.2. BenevolentAI
    • 13.1.3. Berg LLC
    • 13.1.4. Bioxcel Therapeutics, Inc.
    • 13.1.5. Enlitic Inc.
    • 13.1.6. Google LLC by Alphabet Inc.
    • 13.1.7. InSilico Medicine
    • 13.1.8. Intel Corporation
    • 13.1.9. International Business Machines Corporation
    • 13.1.10. Microsoft Corporation
    • 13.1.11. NVIDIA Corporation
    • 13.1.12. PathAI, Inc.
    • 13.1.13. Recursion Pharmaceuticals, Inc.
    • 13.1.14. Tempus Labs, Inc.
    • 13.1.15. Verge Analytics, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing